+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
UCB (Union chimique belge) - logo

UCB is a global biopharmaceutical company that focuses on neurology and immunology. The company’s core products are Cimzia, Vimpat, Neupro, Keppra and Briviact, and they are also preparing the launch of a potential medicine to help patients with osteoporosis. It offers products for the treatment of central nervous system disorders, allergy and respiratory diseases, and immune and inflammatory disorders. UCB employs over 7,000 people and is based in Brussels, Belgium.

The Corporate Reputation of Pharma in 2021- The Patient Perspective - France Edition - The Views of 109 French Patient Groups - Product Thumbnail Image

The Corporate Reputation of Pharma in 2021- The Patient Perspective - France Edition - The Views of 109 French Patient Groups

  • Report
  • July 2022
  • 60 Pages
  • France
Novel Drug Delivery System Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Novel Drug Delivery System Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • August 2023
  • 115 Pages
  • Global
From
Brand Name Pharmaceutical Manufacturing in the US - Industry Market Research Report - Product Thumbnail Image

Brand Name Pharmaceutical Manufacturing in the US - Industry Market Research Report

  • Report
  • April 2025
  • 53 Pages
  • United States
Europe Mid-Size Pharmaceutical Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Type, Drug Development Type, Formulation, and Therapy Class - Product Thumbnail Image

Europe Mid-Size Pharmaceutical Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Type, Drug Development Type, Formulation, and Therapy Class

  • Report
  • September 2022
  • 73 Pages
  • Europe
From
Bimekizumab Emerging Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

Bimekizumab Emerging Drug Insight and Market Forecast - 2032

  • Report
  • March 2023
  • 30 Pages
  • Global
From
Zilucoplan Emerging Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

Zilucoplan Emerging Drug Insight and Market Forecast - 2032

  • Report
  • March 2023
  • 30 Pages
  • Global
From
Europe Musculoskeletal Disorders Drugs Market Size, Share & Industry Trends Analysis Report By Distribution Channel, By Route of Administration (Parenteral and Oral), By Drug Type (Analgesics, DMARDs, Corticosteroids), By Country and Growth Forecast, 2023 - 2029 - Product Thumbnail Image

Europe Musculoskeletal Disorders Drugs Market Size, Share & Industry Trends Analysis Report By Distribution Channel, By Route of Administration (Parenteral and Oral), By Drug Type (Analgesics, DMARDs, Corticosteroids), By Country and Growth Forecast, 2023 - 2029

  • Report
  • May 2023
  • 103 Pages
  • Europe
From
LAMEA Musculoskeletal Disorders Drugs Market Size, Share & Industry Trends Analysis Report By Distribution Channel, By Route of Administration (Parenteral and Oral), By Drug Type (Analgesics, DMARDs, Corticosteroids), By Country and Growth Forecast, 2023 - 2029 - Product Thumbnail Image

LAMEA Musculoskeletal Disorders Drugs Market Size, Share & Industry Trends Analysis Report By Distribution Channel, By Route of Administration (Parenteral and Oral), By Drug Type (Analgesics, DMARDs, Corticosteroids), By Country and Growth Forecast, 2023 - 2029

  • Report
  • May 2023
  • 102 Pages
  • Africa, Middle East
From
North America Musculoskeletal Disorders Drugs Market Size, Share & Industry Trends Analysis Report By Distribution Channel, By Route of Administration (Parenteral and Oral), By Drug Type (Analgesics, DMARDs, Corticosteroids), By Country and Growth Forecast, 2023 - 2029 - Product Thumbnail Image

North America Musculoskeletal Disorders Drugs Market Size, Share & Industry Trends Analysis Report By Distribution Channel, By Route of Administration (Parenteral and Oral), By Drug Type (Analgesics, DMARDs, Corticosteroids), By Country and Growth Forecast, 2023 - 2029

  • Report
  • May 2023
  • 92 Pages
  • North America
From
Asia Pacific Musculoskeletal Disorders Drugs Market Size, Share & Industry Trends Analysis Report By Distribution Channel, By Route of Administration (Parenteral and Oral), By Drug Type (Analgesics, DMARDs, Corticosteroids), By Country and Growth Forecast, 2023 - 2029 - Product Thumbnail Image

Asia Pacific Musculoskeletal Disorders Drugs Market Size, Share & Industry Trends Analysis Report By Distribution Channel, By Route of Administration (Parenteral and Oral), By Drug Type (Analgesics, DMARDs, Corticosteroids), By Country and Growth Forecast, 2023 - 2029

  • Report
  • May 2023
  • 104 Pages
  • Asia Pacific
From
Inflammatory Bowel Disease Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update - Product Thumbnail Image

Inflammatory Bowel Disease Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update

  • Report
  • April 2023
  • 2262 Pages
  • Global
From
Spondyloarthritis Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update - Product Thumbnail Image

Spondyloarthritis Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update

  • Report
  • April 2023
  • 147 Pages
  • Global
From
Precision and Personalized Medicine in Pharma - Thematic Intelligence - Product Thumbnail Image

Precision and Personalized Medicine in Pharma - Thematic Intelligence

  • Report
  • June 2023
  • 62 Pages
  • Global
From
Injectable Drug Delivery Device Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Injectable Drug Delivery Device Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • July 2023
  • 93 Pages
  • Global
From
Injectable Drug Delivery Technology Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Product Type - Product Thumbnail Image

Injectable Drug Delivery Technology Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Product Type

  • Report
  • June 2023
  • 126 Pages
  • Global
From
Multiple System Atrophy (MSA or Shy-Drager Syndrome or Multi-System Degeneration) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Multiple System Atrophy (MSA or Shy-Drager Syndrome or Multi-System Degeneration) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • November 2022
  • 99 Pages
  • Global
From
Parkinson's Disease: Global Drug Forecast and Market Analysis to 2026 - Product Thumbnail Image

Parkinson's Disease: Global Drug Forecast and Market Analysis to 2026

  • Report
  • May 2018
  • 127 Pages
  • Global
From
Pharma Industry Mergers and Acquisitions Deals by Top Themes in 2022 - Thematic Intelligence - Product Thumbnail Image

Pharma Industry Mergers and Acquisitions Deals by Top Themes in 2022 - Thematic Intelligence

  • Report
  • February 2023
  • 22 Pages
  • Global
From
UCB SA Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis - Product Thumbnail Image

UCB SA Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

  • Company Profile
  • December 2025
  • 50 Pages
From
UCB SA (UCB) - Financial and Strategic SWOT Analysis Review - Product Thumbnail Image

UCB SA (UCB) - Financial and Strategic SWOT Analysis Review

  • SWOT Analysis
  • September 2025
  • 71 Pages
From
Loading Indicator